Inclusive of all taxes
Free Express Secure Delivery
Protective climate-sealed dispatch across India within 4 to 24 hours.
Order through WhatsAppFinancial Assistance Available
Manufacturer patient assistance program (PAP) available for Tagrisso 80mg Tablet. Eligible patients can access subsidized treatment schemes.
About this medicine
Tagrisso 80mg Tablet (Osimertinib (80mg))is a prescription oncology medicine. Below is educational product information — follow your doctor's advice for dose and use.
Tagrisso 80mg Tablet is a protein kinase inhibitor used in the treatment of non-small cell lung cancer. It is used in the treatment of adult patients who have certain estimated glomerular filtration rate (EGFR) mutations.This medicine can be taken with or without food, but try to have it at the same time every day to get the most benefits. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.Diarrhea is very common side effect of this medicine, so drink plenty of fluids. But, you must inform your doctor if it does not stop. You must have to inform your doctor if you experience difficulty in breathing along with fever and cough, or severe peeling of the skin. This medicine may reduce the number of blood cells (decrease white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells.Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.
Quick Facts
Generic Name
Osimertinib (80mg)
Dosage Form
Tablet
Prescription Status
Doctor's Rx Required
Uses of Tagrisso 80mg Tablet
Side Effects of Tagrisso 80mg Tablet
Oncology medicines should be administered strictly under medical supervision. Inform your oncologist immediately if you experience adverse symptoms.
Clinical Safety Advice for Tagrisso 80mg Tablet
Follow expert clinical guidelines regarding interactions, precautions, and medical conditions when taking Tagrisso 80mg Tablet.
It is not known whether it is safe to consume alcohol with Tagrisso 80mg Tablet. Please consult your doctor.
Tagrisso 80mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Tagrisso 80mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Tagrisso 80mg Tablet does not usually affect your ability to drive.
Tagrisso 80mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Tagrisso 80mg Tablet is recommended.
Tagrisso 80mg Tablet is safe to use in patients with liver disease. No dose adjustment of Tagrisso 80mg Tablet is recommended.
Storage & Delivery Protocol
Preservation and climate-safe dispatch guidelines for Tagrisso 80mg Tablet across India.
Storage Conditions
Store in the original container at temperatures below 30°C (86°F). Protect from moisture and direct sunlight. Keep out of reach of children and pets. This medication does not require 2°C–8°C refrigeration.
Climate-Sealed Transit
Dispatched in protective, tamper-evident and moisture-sealed packaging.
Rx Verification
Prescription and genuine batch validated prior to dispatch.
Frequently Asked Questions
Have questions about your cancer prescription?
Our licensed oncology pharmacists are available to assist with medicine availability, cold-chain handling, and prescription verification.